Exagen (XGN) Treasury Shares (2021 - 2026)

Exagen (XGN) has reported Treasury Shares for 6 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.

• Treasury Shares for Q1 2026 came in at $2.1 million, up 16.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (up 16.85% YoY), and the FY2025 annual result was $1.8 million, up 4.99% from the prior year.
• Treasury Shares was $2.1 million for Q1 2026 at Exagen, up from $1.8 million in the prior quarter.
• Over five years, Treasury Shares peaked at $2.1 million in Q1 2026 and troughed at $784940.0 in Q2 2022.
• Average Treasury Shares over 5 years is $1.5 million, with a median of $1.7 million recorded in 2024.
• Year-over-year, Treasury Shares surged 374.91% in 2022 and declined 2.52% in 2025.
• Over 5 years, Treasury Shares stood at $1.0 million in 2022, then jumped by 33.9% to $1.4 million in 2023, then advanced by 23.27% to $1.7 million in 2024, then increased by 4.99% to $1.8 million in 2025, then advanced by 18.6% to $2.1 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $2.1 million in Q1 2026, $1.8 million in Q4 2025, and $1.8 million in Q3 2025.